Get my own profile
Public access
View all81 articles
8 articles
available
not available
Based on funding mandates
Co-authors
Kent KirshenbaumProfessor of Chemistry, New York UniversityVerified email at nyu.edu
Nitash P. BalsaraUniversity of California, Berkeley, and Lawrence Berkeley National LaboratoryVerified email at berkeley.edu
Rachel SegalmanEdward Noble Kramer Professor of Materials, Dept. Chair of Chemical Engineering, UCSBVerified email at ucsb.edu
Ken A. DillDirector of Laufer Center, Stony Brook UniversityVerified email at laufercenter.org
F E CohenUCSFVerified email at pacbell.net
Walter H MoosUCSF, Pandect Bioventures, ShangPharma Innovation, SRI (Stanford Research Institute), MitoKorVerified email at ucsf.edu
Sunting XuanSoochow UniversityVerified email at suda.edu.cn
Eric J. MartinNovartisVerified email at novartis.com
Xi JiangLawrence Berkeley National LaboratoryVerified email at lbl.gov
Ryan K SpencerProtomer Technologies, a wholly-owned subsidiary of Eli Lilly and companyVerified email at uci.edu
Stephen WhitelamStaff Scientist, Lawrence Berkeley National LabVerified email at lbl.gov
Caroline ProulxNorth Carolina State UniversityVerified email at ncsu.edu
David PrendergastMolecular Foundry, Lawrence Berkeley National LaboratoryVerified email at lbl.gov
Helen TranUniversity of TorontoVerified email at utoronto.ca
Babak SaniiNutcracker TherapeuticsVerified email at nutcrackerx.com
Glenn ButterfossProteinQureVerified email at proteinqure.com
Adrianne RosalesAssistant Professor, University of Texas at AustinVerified email at che.utexas.edu
Ranjan MannigeCerevel TherapeuticsVerified email at lbl.gov
Ki Tae NamProfessor, Department of Materials Science and Engineering, Seoul National UniversityVerified email at snu.ac.kr
Deborah CharychNektar TherapeuticsVerified email at nektar.com
Follow
Ronald N. Zuckermann
Molecular Foundry, Lawrence Berkeley National Laboratory
Verified email at lbl.gov - Homepage